VEEA INC SEC Filings

Allen Salmasi, CEO and director of Veea Inc. reported purchases tied to a public best-efforts offering. On 08/14/2025, 5,239,096 shares of common stock were acquired at $1.00 per share and 5,239,096 common warrants were issued with a $1.10 exercise price and 08/14/2030 expiration. After the transactions, Mr. Salmasi directly owned 17,388,017 shares and, indirectly through NLabs Inc., beneficial ownership increased to 21,124,580 shares. NLabs Inc., of which Mr. Salmasi is CEO and stockholder, received the shares and warrants from the offering; Mr. Salmasi disclaims beneficial ownership except to the extent of pecuniary interest. The Form 4 is signed by Allen Salmasi and NLabs Inc.'s authorized signer on 08/27/2025.

Ursula M. Burns reported beneficial ownership of 2,054,745 shares of Veea Inc., representing 4.0% of the company based on 50,182,879 shares outstanding. The position comprises 960,061 currently outstanding shares, 121,326 earnout shares that vest only if specified VWAP thresholds ($12.50 and $15.00) are met by September 13, 2034 (or earlier on a change in control), and warrants to purchase 973,358 shares at $11.50 per share that expire September 13, 2029. The filing states these securities were not acquired to change or influence control of the issuer.

Veea Inc. reported continued operating losses and strained liquidity. The company recorded operating losses of $10.7 million for the six months ended June 30, 2025 and $12.4 million for the comparable 2024 period, and an accumulated deficit of $220.9 million as of June 30, 2025. At that date Veea had $238,008 in cash and $20.2 million of outstanding debt made up of convertible notes, a $14.0 million working capital facility, related party loans of $2.626 million and other vendor notes.

The company completed an acquisition of Crowdkeep with equity consideration valued at $6.957 million and recognized an earn-out share liability initially valued at $53.6 million. Management states it has received additional related party and external loans since January 1, 2025 and believes it has "alleviated substantial doubt" about going concern through planned financings including an Offering, an equity line (ELOC), expected UK tax refunds up to $1.0 million, and potential additional investments, but notes there is no assurance these plans will succeed.

Veea Inc. filed an 8-K reporting material events related to its common stock (ticker VEEA) and associated warrants (ticker VEEAW). The filing lists exhibits including a Form of Warrant, a Form of Securities Purchase Agreement, and a Placement Agency Agreement dated August 12, 2025. Two press releases dated August 13, 2025 and August 14, 2025 are included as exhibits, and the cover page interactive data file is embedded. The filing is signed on behalf of Veea Inc. with a date of August 15, 2025, but the signatory name and title are not provided in the text supplied.

Veea Inc. is offering 9,239,096 shares of common stock together with 9,239,096 common warrants at a combined public offering price of $1.00 per share and accompanying warrant. Each warrant is exercisable for one share at $1.10, exercisable immediately and expiring five years from issuance. The offering includes 3,239,096 shares and warrants to existing stockholders in full satisfaction of related-party promissory notes totaling approximately $3,239,096. The placement agent fee structure includes cash fees of 7.0% for investors introduced by the agent and 3.5% for investors introduced by the company, and estimated proceeds to the company before expenses are ~$5,580,000 with net proceeds estimated at ~$5.3 million. The company reported its common stock last sale on Nasdaq at $1.06 on August 12, 2025. Common warrants are not expected to trade on any national exchange. The offering is on a reasonable best efforts basis, expected single closing, and will end no later than August 25, 2025.

Veea Inc. filed a Registration Statement on Form S-1 pursuant to Rule 462(b) to register additional securities under its prior S-1 (File No. 333-288878), which the SEC declared effective on August 12, 2025. The filing increases the maximum aggregate offering price by $1,402,101.60, consisting of $239,096 of common stock and $1,163,005.60 of common warrants. The additional securities equal no more than 20% of the maximum aggregate offering price shown in Exhibit 107 to the prior registration statement.

The registrant certifies it will pay the required SEC filing fee by wire no later than the close of business on August 14, 2025, and lists exhibits including legal opinion, auditor consent, power of attorney, and the filing-fee table. The company identifies its principal executive office at 164 E. 83rd Street, New York, NY, and indicates status as a non-accelerated filer, smaller reporting company and emerging growth company. The filing is signed by CEO Allen Salmasi and other officers/representatives as indicated.

Veea Inc. files an Amendment No. 2 to its Form S-1 to raise up to $9.0 million by offering up to 6,206,897 shares and related pre-funded warrants and common warrants at an assumed combined public offering price of $1.45 per share and accompanying warrant. The common warrants have an assumed exercise price of $1.45 and expire five years after initial exercisability; pre-funded warrants have a <$0.001> exercise price and are immediately exercisable. The offering is on a reasonable best efforts basis via A.G.P./Alliance Global Partners and may close by August 25, 2025.

The prospectus discloses an expected $5.4 million of net proceeds after fees and expenses (assuming full sale), and contemplates satisfying related-party promissory notes held by NLabs (~$3.24 million including accrued interest) through issuance of ~2,232,659 shares and accompanying warrants. After the offering the company estimates 47,200,680 shares outstanding (from 40,993,783). The filing highlights VeeaONE edge-cloud platform, a patent portfolio ( 123 granted patents, 32 pending ), and a soft launch with an MNO partner and a non-binding strategic commercial alliance signed in May 2025. The prospectus also emphasizes material risks including limited product revenue since 2024, recurring losses, significant capital needs, potential dilution, and related-party transactions.